Key enzyme plays roles as both friend and foe to cancer

June 14, 2012
Nissim Hay, Professor, Biochemistry and Molecular Genetics. Image: University of Illinois at Chicago

A molecule thought to limit cell proliferation also helps cancer cells survive during initial tumor formation and when the wayward cells spread to other organs in the body, researchers at the University of Illinois at Chicago College of Medicine have found.

The study was published in the May 31 issue of Nature.

The new study seems to contradict earlier findings that activation of the enzyme, called AMP-activated protein kinase, or AMPK, inhibits the growth of cells in culture.

Because of its role in inhibiting and proliferation, AMPK has been viewed as a promising potential target for developing new chemotherapy drugs, says Nissim Hay, professor of biochemistry and molecular genetics at UIC and principle investigator on the study.

But Hay and his colleagues found that when the cell is under , AMPK is activated to promote cell survival and prevent cell death.

"Paradoxically, activated AMPK is actually required for the survival of the cancer cell during metabolic stress, when is decreased," Hay said. are subjected to metabolic stress when they first leave the cell matrix to form a solid tumor, and again when they migrate out of the tumor to spread throughout the body.

The researchers found that AMPK promotes the survival of cancer cells by indirectly regulating NADPH, a molecule that reduces harmful reactive-oxygen species. They showed that AMPK exerts it effect by regulating enzymes that control and fatty acid oxidation.

The new study may also help to explain a previous unexpected finding: that cells that are deficient in AMPK, or in another enzyme that is responsible for activating AMPK, called LKB1, are resistant to becoming cancerous. Patients with Peuta-Jeghers syndrome, an inherited deficiency of LKB1, develop only incapable of spreading.

, through its role in limiting proliferation, may still offer a promising target for chemotherapy, Hay said, but it would be important to target the fatty acid synthesis enzymes at the same time in order to block AMPK's protective effect.

The study was supported by grants from the National Institutes of Health; the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust; and the Diabetes Research and Training Center at the University of Chicago.

Sang-Min Jeon, former UIC graduate student, is first author on the study. He is now on staff at Genetech in San Francisco. Navdeep Chandel, professor of pulmonary and critical care medicine at Northwestern University, also contributed to the study.

Explore further: AMPK amplifies Huntington's disease

Related Stories

AMPK amplifies Huntington's disease

July 18, 2011
A new study describes how hyperactivation of AMP-activated protein kinase (AMPK) promotes neurodegeneration in Huntington's disease (HD). The article appears online on July 18, 2011, in The Journal of Cell Biology.

Blocking receptor in key hormone fires up enzyme to kill pancreatic cancer cells

August 10, 2011
Pancreatic cancer researchers at Thomas Jefferson University have shown, for the first time, that blocking a receptor of a key hormone in the renin-angiotensin system (RAS) reduces cancer cell growth by activating the enzyme ...

Cell energy sensor mechanism discovered: Studies linked to better understanding of cancer drugs

February 21, 2012
Johns Hopkins and National Taiwan University researchers have discovered more details about how an energy sensing "thermostat" protein determines whether cells will store or use their energy reserves.

Recommended for you

A sodium surprise: Engineers find unexpected result during cardiac research

July 20, 2017
Irregular heartbeat—or arrhythmia—can have sudden and often fatal consequences. A biomedical engineering team at Washington University in St. Louis examining molecular behavior in cardiac tissue recently made a surprising ...

Want to win at sports? Take a cue from these mighty mice

July 20, 2017
As student athletes hit training fields this summer to gain the competitive edge, a new study shows how the experiences of a tiny mouse can put them on the path to winning.

Engineered liver tissue expands after transplant

July 19, 2017
Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available.

Lunatic Fringe gene plays key role in the renewable brain

July 19, 2017
The discovery that the brain can generate new cells - about 700 new neurons each day - has triggered investigations to uncover how this process is regulated. Researchers at Baylor College of Medicine and Jan and Dan Duncan ...

'Smart' robot technology could give stroke rehab a boost

July 19, 2017
Scientists say they have developed a "smart" robotic harness that might make it easier for people to learn to walk again after a stroke or spinal cord injury.

New animal models for hepatitis C could pave the way for a vaccine

July 19, 2017
They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.